Charité Research Organisation

Charité Research Organisation specializes in the design and conduct of early-phase clinical trials, particularly First Time in Human to Proof of Concept studies. They offer full-service capabilities including protocol development, patient recruitment, study conduct in a dedicated Phase I unit with strong academic ties to Charité – Universitätsmedizin Berlin. Their expertise enables efficient transition from preclinical to early human data for novel therapeutics[1][2][3][4].

As a service provider/CRO, they do not publish their own drug trial results.

They are operationally and economically independent from the university hospital but benefit from close collaboration[4].

No proprietary pipeline; supports external sponsors’ pipelines.

Estimated revenue ranges between $4 million and $18.3 million annually; employs approximately 87–116 people as of recent reports[3][5].

Founded in Berlin in collaboration with Germany’s largest university hospital.

CEO & CSO is Prof. Frank Wagner; Associate Director Business Operations is Thomas Bemmann[4].